ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2278

Orbital Pseudotumor As the Presenting Symptom of Pediatric ANCA-Associated Vasculitis

Amanda Schlefman1, Maureen Leffler2, AnneMarie C. Brescia3 and Carlos D. Rose4, 1A.I. DuPont Hospital for Children, Wilmington, DE, 2Rheumatology, AI duPont Hospital for Children, Wilmington, DE, 3Pediatric Rheumatology, Thomas Jefferson University/ AI duPont Hospital for Children, Wilmington, DE, 4Pediatrics, Division of Rheumatology, Nemours A.I. duPont Hospital for Children, Thomas Jefferson University, Wilmington, DE

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: ANCA, ocular involvement, pediatrics and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Systemic Juvenile Idiopathic Arthritis, Spondyloarthropathy and Miscellaneous Pediatric Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: Ocular involvement, particularly orbital pseudotumor, has been reported as the initial manifestation of ANCA-associated vasculitis (AAV) in the adult population, predominantly in granulomatosis with polyangiitis (GPA) with less frequency in Churg-Strauss syndrome (CSS) and microscopic polyangiitis (MPA).  There are several cases in the literature of pediatric patients with GPA presenting with orbital pseudotumor, however to our knowledge there are no published cases of this type of presentation in childhood CSS or MPA.

Methods: During the period between 2009 and 2014 three cases of orbital pseudotumor were diagnosed in our Pediatric Rheumatology Division.  A thorough chart review was conducted on these patients regarding clinical presentation, laboratory data, imaging studies and pathology.  A literature review was then completed in PubMed looking for individual reports of pediatric ANCA-associated vasculitis, as well as previously reported cases of orbital pseudotumor in both adults and children.

Results: Four reports in PubMed were published regarding orbital pseudotumor and ANCA-associated vasculitis in pediatrics.  Within these studies there were 15 cases of pediatric AAV presenting as orbital pseudotumor, all of which were limited to GPA.  There was no published evidence of this initial presentation in either CSS or MPA in the pediatric population. The characteristics of our patients are listed below:

 

OrbPSTTable.jpg

 

OrbPSTMRI.jpg

 

Conclusion: When pediatric patients present with orbital pseudotumor the differential should be widened regarding types of ANCA-associated vasculitides to include CSS and MPA.  Recognizing these possibilities would allow for early screening and monitoring for potential multi-organ involvement.


Disclosure:

A. Schlefman,
None;

M. Leffler,
None;

A. C. Brescia,
None;

C. D. Rose,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/orbital-pseudotumor-as-the-presenting-symptom-of-pediatric-anca-associated-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology